Region: Global
Category: Diseases & Conditions

Global Diseases & Conditions

(10,699 reports matching your criteria)
  • 2025 Global Gene Therapy For Ovarian Cancer Market Industry (2031 Outlook)

    ... size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market ... Read More

  • Gout Therapeutics

    ... CAGR of 13.4% over the analysis period 2024-2030. NSAIDs, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$4.7 Billion by the end of the analysis period. ... Read More

  • Pesticide Inert Ingredients

    ... at a CAGR of 6.2% over the analysis period 2024-2030. Emulsifiers, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$3.3 Billion by the end of the ... Read More

  • Migraine Drugs

    ... CAGR of 16.0% over the analysis period 2024-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$7.2 Billion by the end of the analysis ... Read More

  • Tuberculosis Therapeutics

    ... CAGR of 2.7% over the analysis period 2024-2030. Active TB, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$654.3 Million by the end of the analysis ... Read More

  • Anxiety Disorder Treatment

    ... at a CAGR of 2.4% over the analysis period 2024-2030. Antidepressants, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$4.9 Billion by the end of the ... Read More

  • Automotive Rubber-Molded Components

    ... at a CAGR of 5.4% over the analysis period 2024-2030. Ethylene Propylene Diene Monomer (EPDM), one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$31.1 Billion by ... Read More

  • Booster Compressors

    ... CAGR of 5.4% over the analysis period 2024-2030. Air-Cooled Compressors, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$3.3 Billion by the end of the analysis ... Read More

  • Central Venous Catheters (CVCs)

    ... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Multi-Lumen, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$971.4 Million by the end ... Read More

  • Cycling Power Meters

    ... at a CAGR of 4.4% over the analysis period 2024-2030. Sports Bicycle, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$300.2 Million by the end of ... Read More

  • Healthcare BPO

    ... CAGR of 9.4% over the analysis period 2024-2030. Provider Service, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$234.8 Billion by the end of the analysis ... Read More

  • OTT Devices and Services

    ... 2030, growing at a CAGR of 17.9% over the analysis period 2024-2030. Video, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$252.9 Billion by the end ... Read More

  • Nail Care

    ... CAGR of 2.6% over the analysis period 2024-2030. Nail polishes, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$8.3 Billion by the end of the analysis ... Read More

  • Thoracic Drainage Devices

    ... at a CAGR of 4.6% over the analysis period 2024-2030. Thoracic Surgery & Pulmonology, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$528.6 Million by the ... Read More

  • Intraoperative Radiation Therapy

    ... at a CAGR of 6.0% over the analysis period 2024-2030. Systems / Accelerators, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$22.9 Million by the end ... Read More

  • Optical Imaging Techniques

    ... at a CAGR of 10.1% over the analysis period 2024-2030. Optical Coherence Tomography, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$3.2 Billion by the end ... Read More

  • Pet Care

    ... CAGR of 6.1% over the analysis period 2024-2030. Pet Food, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$136.3 Billion by the end of the analysis ... Read More

  • Office Administrative Services

    ... at a CAGR of 7.9% over the analysis period 2024-2030. Administrative Management Services, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$62.1 Billion by the end ... Read More

  • Ultraviolet Germicidal Irradiation (UVGI)

    ... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Air Disinfectant, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$928.6 Million by the ... Read More

  • Cadaver Bags

    ... CAGR of 4.9% over the analysis period 2024-2030. PVC, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$554.9 Million by the end of the analysis period. ... Read More

  • Sports Management Software

    ... at a CAGR of 13.2% over the analysis period 2024-2030. Cloud, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$8.2 Billion by the end of the ... Read More

  • Rapid Antigen Detection Tests

    ... 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$88.4 Million While China is Forecast to Grow at 12.4% CAGR The Rapid Antigen Detection Tests market ... Read More

  • Knee Braces

    ... CAGR of 5.2% over the analysis period 2024-2030. Functional, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$875.4 Million by the end of the analysis period. ... Read More

  • Blood Glucose Monitoring Systems

    ... 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Self-Monitoring, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$21.4 Billion by the end ... Read More

  • Allergy Treatment

    ... CAGR of 3.7% over the analysis period 2024-2030. Asthma, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$5.9 Billion by the end of the analysis period. ... Read More

Cookie Settings